These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 37315498)
1. Effectiveness of China-PAR and Framingham risk score in assessment of 10-year cardiovascular disease risk in Chinese hypertensive patients. Chen X; Tu Q; Wang D; Liu J; Qin Y; Zhang Y; Xiang Q Public Health; 2023 Jul; 220():127-134. PubMed ID: 37315498 [TBL] [Abstract][Full Text] [Related]
2. [Application of the China-PAR stroke risk equations in a rural northern Chinese population]. Tang X; Zhang DD; Liu XF; Liu QP; Cao Y; Li N; Huang SP; Dou HD; Gao P; Hu YH Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 52(3):444-450. PubMed ID: 32541976 [TBL] [Abstract][Full Text] [Related]
3. Comparative Analysis of Three Atherosclerotic Cardiovascular Disease Risk Prediction Models in Individuals Aged 75 and Older. Wang Z; Yang X; Li L; Zhang X; Zhou W; Chen S Clin Interv Aging; 2024; 19():529-538. PubMed ID: 38525315 [TBL] [Abstract][Full Text] [Related]
4. [Application of the China-PAR risk prediction model for atherosclerotic cardiovascular disease in a rural northern Chinese population]. Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Huang SP; Dou HD; Gao P; Hu YH Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):439-445. PubMed ID: 28628144 [TBL] [Abstract][Full Text] [Related]
5. External validation of three atherosclerotic cardiovascular disease risk equations in rural areas of Xinjiang, China. Jiang Y; Ma R; Guo H; Zhang X; Wang X; Wang K; Hu Y; Keerman M; Yan Y; Ma J; Song Y; Zhang J; He J; Guo S BMC Public Health; 2020 Sep; 20(1):1471. PubMed ID: 32993590 [TBL] [Abstract][Full Text] [Related]
6. The predictive accuracy of coronary heart disease risk prediction models in rural Northwestern China. Qiu J; Chang Z; Wang K; Chen K; Wang Q; Zhang J; Li J; Yang C; Zhao Y; Zhang Y Prev Med Rep; 2023 Dec; 36():102503. PubMed ID: 38116288 [TBL] [Abstract][Full Text] [Related]
7. Traditional Cardiovascular Risk Factors Strongly Underestimate the 5-Year Occurrence of Cardiovascular Morbidity and Mortality in Spinal Cord Injured Individuals. Barton TJ; Low DA; Bakker EA; Janssen T; de Groot S; van der Woude L; Thijssen DHJ Arch Phys Med Rehabil; 2021 Jan; 102(1):27-34. PubMed ID: 32861666 [TBL] [Abstract][Full Text] [Related]
8. [Accuracy of the China-PAR and WHO risk models in predicting the ten-year risks of cardiovascular disease in the Chinese population]. Chen WY; Liu XF; Shen P; Chen Q; Sun YX; Wu JG; Lu P; Zhang JY; Lin HB; Tang X; Gao P Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Aug; 43(8):1275-1281. PubMed ID: 35981990 [No Abstract] [Full Text] [Related]
9. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study. Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290 [TBL] [Abstract][Full Text] [Related]
10. A Simple Model for Predicting 10-Year Cardiovascular Risk in Middle-Aged to Older Chinese: Guangzhou Biobank Cohort Study. Huang YY; Tian WB; Jiang CQ; Zhang WS; Zhu F; Jin YL; Lam TH; Xu L; Cheng KK J Cardiovasc Transl Res; 2022 Apr; 15(2):416-426. PubMed ID: 34402029 [TBL] [Abstract][Full Text] [Related]
11. [Effectiveness of different screening strategies for primary prevention of cardiovascular diseases in a rural northern Chinese population]. Si YQ; Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Liu JJ; Gao P; Hu YH Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):443-449. PubMed ID: 29930411 [TBL] [Abstract][Full Text] [Related]
12. Validation of the China-PAR Equations for Cardio-cerebrovascular Risk Prediction in the Inner Mongolian Population. Zeng NM; Zheng XW; Peng H; Jiao Y; Li HM; Zhang MZ; Wang AL; Zhang YH Biomed Environ Sci; 2018 Jun; 31(6):463-466. PubMed ID: 30025560 [TBL] [Abstract][Full Text] [Related]
13. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10. Riddell T; Wells S; Jackson R; Lee AW; Crengle S; Bramley D; Ameratunga S; Pylypchuk R; Broad J; Marshall R; Kerr A N Z Med J; 2010 Feb; 123(1309):50-61. PubMed ID: 20186242 [TBL] [Abstract][Full Text] [Related]
14. [A comparison between the metabolic syndrome score and the Framingham risk score in the prediction of cardiovascular disease]. Yu H; Guo ZR; Hu XS; Zhou ZY; Wu M Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Feb; 31(2):208-12. PubMed ID: 21215086 [TBL] [Abstract][Full Text] [Related]
15. Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study. Chia YC; Gray SY; Ching SM; Lim HM; Chinna K BMJ Open; 2015 May; 5(5):e007324. PubMed ID: 25991451 [TBL] [Abstract][Full Text] [Related]
16. Computed tomography-derived cardiovascular risk markers, incident cardiovascular events, and all-cause mortality in nondiabetics: the Multi-Ethnic Study of Atherosclerosis. Yeboah J; Carr JJ; Terry JG; Ding J; Zeb I; Liu S; Nasir K; Post W; Blumenthal RS; Budoff MJ Eur J Prev Cardiol; 2014 Oct; 21(10):1233-41. PubMed ID: 23689526 [TBL] [Abstract][Full Text] [Related]
17. Performance of atherosclerotic cardiovascular risk prediction models in a rural Northern Chinese population: Results from the Fangshan Cohort Study. Tang X; Zhang D; He L; Wu N; Si Y; Cao Y; Huang S; Li N; Li J; Dou H; Gao P; Hu Y Am Heart J; 2019 May; 211():34-44. PubMed ID: 30831332 [TBL] [Abstract][Full Text] [Related]
18. Validation and comparison of cardiovascular risk prediction equations in Chinese patients with Type 2 diabetes. Liang J; Li Q; Fu Z; Liu X; Shen P; Sun Y; Zhang J; Lu P; Lin H; Tang X; Gao P Eur J Prev Cardiol; 2023 Sep; 30(12):1293-1303. PubMed ID: 37315163 [TBL] [Abstract][Full Text] [Related]
19. Comparison of validation and application on various cardiovascular disease mortality risk prediction models in Chinese rural population. Sun C; Xu F; Liu X; Fang M; Zhou H; Lian Y; Xie C; Sun N; Wang C Sci Rep; 2017 Mar; 7():43227. PubMed ID: 28337999 [TBL] [Abstract][Full Text] [Related]